Drawing for HEOS

USPTO serial 79221340

HEOS

Reviewed by CopyMark Law Group

Reg. 5588480Status 709
Filing date
Status date
Registration date
Oct 23, 2018
Examiner
PODESTA, GIDETTE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical Endoscopes; endoscopes for diagnostic, therapeutic, medical, surgical use; electronic endoscopes for surgical, medical use; medical rigid endoscopes; optical instruments for medical endoscopy; medical apparatus for use in endoscopySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 12, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 12, 2026INPCINVALIDATION PROCESSED—
Jan 9, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 9, 2025C71TCANCELLED SECTION 71—
Oct 23, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 22, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2019FIMPFINAL DISPOSITION PROCESSED—
Jan 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 23, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 7, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 7, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 4, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 18, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 18, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 3, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 1, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 22, 2018ALIEASSIGNED TO LIE—
Jun 11, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 11, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 18, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 18, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 9, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 7, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2017DOCKASSIGNED TO EXAMINER—
Dec 5, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance